Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk
WSJ·2025-11-06 05:52公司动态 - 辉瑞公司正计划再次提高对减肥药初创公司Metsera的收购报价 [1] - Metsera公司目前是诺和诺德参与的竞购战的核心标的 [1] 行业竞争 - 减肥药领域竞争激烈，已出现针对初创公司的多方竞购战 [1] - 诺和诺德作为行业主要参与者亦参与对Metsera的竞购 [1]